152 related articles for article (PubMed ID: 33219741)
1. Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
D'Angelo P; De Pasquale MD; Barretta F; Affinita MC; Conte M; Dall'Igna P; Di Cataldo A; Inserra A; Provenzi M; Quaglietta L; Riccipetitoni G; Spreafico F; Trizzino A; Terenziani M;
Pediatr Blood Cancer; 2021 Mar; 68(3):e28812. PubMed ID: 33219741
[TBL] [Abstract][Full Text] [Related]
2. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Terenziani M; Bisogno G; Boldrini R; Cecchetto G; Conte M; Boschetti L; De Pasquale MD; Biasoni D; Inserra A; Siracusa F; Basso ME; De Leonardis F; Di Pinto D; Barretta F; Spreafico F; D'Angelo P
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
[TBL] [Abstract][Full Text] [Related]
3. Malignant testicular germ cell tumors in children and adolescents: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) protocol.
Terenziani M; De Pasquale MD; Bisogno G; Biasoni D; Boldrini R; Collini P; Conte M; Dall'Igna P; Inserra A; Melchionda F; Siracusa F; Spreafico F; Barretta F; D'Angelo P
Urol Oncol; 2018 Nov; 36(11):502.e7-502.e13. PubMed ID: 30249520
[TBL] [Abstract][Full Text] [Related]
4. Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
De Pasquale MD; D'Angelo P; Crocoli A; Boldrini R; Conte M; Bisogno G; Spreafico F; Inserra A; Biasoni D; Dall'Igna P; Siracusa F; Miele E; Terenziani M
Pediatr Blood Cancer; 2020 Mar; 67(3):e28125. PubMed ID: 31850649
[TBL] [Abstract][Full Text] [Related]
5. Teratoma with a malignant somatic component in pediatric patients: the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Terenziani M; D'Angelo P; Bisogno G; Boldrini R; Cecchetto G; Collini P; Conte M; De Laurentis T; Ilari I; Indolfi P; Inserra A; Piva L; Siracusa F; Spreafico F; Tamaro P; Lo Curto M
Pediatr Blood Cancer; 2010 Apr; 54(4):532-7. PubMed ID: 20049928
[TBL] [Abstract][Full Text] [Related]
6. Unusual presentation of sacrococcygeal teratomas and associated malformations in children: clinical experience and review of the literature.
Paradies G; Zullino F; Orofino A; Leggio S
Ann Ital Chir; 2013; 84(3):333-46. PubMed ID: 23160138
[TBL] [Abstract][Full Text] [Related]
7. Malignant sacrococcygeal germ cell tumors in children: a 30-year experience from a single institution.
Büyükpamukçu M; Varan A; Küpeli S; Ekinci S; Yalcin S; Kale G; Yalçin B; Kutluk T; Akyüz C
Tumori; 2013; 99(1):51-6. PubMed ID: 23549000
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
[TBL] [Abstract][Full Text] [Related]
9. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
[TBL] [Abstract][Full Text] [Related]
10. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89.
Göbel U; Schneider DT; Calaminus G; Jürgens H; Spaar HJ; Sternschulte W; Waag K; Harms D
J Clin Oncol; 2001 Apr; 19(7):1943-50. PubMed ID: 11283126
[TBL] [Abstract][Full Text] [Related]
11. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
Rescorla F; Billmire D; Stolar C; Vinocur C; Colombani P; Cullen J; Giller R; Cushing B; Lauer S; Davis M; Hawkins E; Shuster J; Krailo M
J Pediatr Surg; 2001 Jan; 36(1):12-7. PubMed ID: 11150431
[TBL] [Abstract][Full Text] [Related]
12. Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series.
Chen SH; Du CJ; Lai JY; Chang TY; Yang CP; Hung IJ; Jaing TH; Ming YC; Hsueh C
Medicine (Baltimore); 2021 Jan; 100(4):e24323. PubMed ID: 33530223
[TBL] [Abstract][Full Text] [Related]
13. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
[TBL] [Abstract][Full Text] [Related]
14. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
15. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
[TBL] [Abstract][Full Text] [Related]
16. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
17. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
Schneider DT; Wessalowski R; Calaminus G; Pape H; Bamberg M; Engert J; Waag K; Gadner H; Göbel U
J Clin Oncol; 2001 Apr; 19(7):1951-60. PubMed ID: 11283127
[TBL] [Abstract][Full Text] [Related]
19. Is surgical resection and observation sufficient for stage I and II sacrococcygeal germ cell tumors? A case series and review.
Egler RA; Gosiengfiao Y; Russell H; Wickiser JE; Frazier AL
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786428
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
